Theorem Clinical Research

Novo Nordisk

New U.K. health campaign urges people with diabetes to 'TALK Hypos'

Thursday, October 16, 2014 02:27 PM

The TALK Hypos awareness campaign has launched in the U.K., supported by Novo Nordisk and Diabetes U.K., encouraging people with diabetes to report hypoglycemia (hypos) to their doctor or nurse.

More... »


Novo Nordisk establishes obesity research unit in Seattle

Tuesday, September 30, 2014 08:00 AM

Novo Nordisk will establish a new obesity research unit in Seattle, Wash. The new unit is a result of Novo Nordisk's increasing focus on obesity. Its main task will be to identify novel approaches and targets for obesity treatments, while increasing the scientific understanding of existing obesity targets.

More... »


Prostrakan to acquire Archimedes

Friday, July 11, 2014 11:26 AM

ProStrakan Group, a subsidiary of global specialty pharmaceutical company Kyowa Hakko Kirin (KHK), has entered into an agreement with Novo, a private limited liability company fully owned by the Novo Nordisk Foundation, to purchase the entire share capital of Archimedes Pharma for $394 million in cash.

More... »

Novo Nordisk to add 6,000 new jobs in Denmark by 2022

Friday, June 13, 2014 01:10 PM

Global healthcare company Novo Nordisk expects to hire 6,000 new employees in Denmark through 2022, half of whom will work within R&D. According to a Novo Nordisk report, the new jobs will have the derived effect of boosting employment by more than 15,000 jobs nationally.

More... »

Despite fewer healthcare deals, corporate venture capital booming

Friday, May 16, 2014 12:39 PM

While last year’s boom in corporate venture capital financing continues to expand in some business sectors, the healthcare space raised only $288 million in 23 deals in the first quarter of 2014—the lowest in five quarters.

More... »

Adapting the recruitment paradigm from site-driven to community-driven

Monday, May 5, 2014 07:00 AM

In January of this year, Danish company Novo Nordisk joined the ranks of digital pharma pioneers by announcing it would use e-recruitment programs in parallel with traditional recruitment techniques for clinical studies in Denmark, Sweden and Norway.

More... »

Novo Nordisk releases positive results in N8-GP trial

Thursday, March 20, 2014 03:22 PM

Novo Nordisk has completed pathfinder2, the first phase III trial with long-acting recombinant factor VIII, N8-GP (turoctocog alfa pegol) for hemophilia A patients. Pathfinder2 is a multi-national trial evaluating safety and efficacy of N8-GP, when administered for prophylaxis and on-demand treatment  in patients with hemophilia A, who are 12 years or older. 

More... »

Innate Pharma acquires ANTI-NKG2A from Novo Nordisk

Monday, February 10, 2014 10:19 AM

Innate Pharma has acquired full development and commercialization rights to the anti-NKG2A antibody, a first-in-class immune checkpoint inhibitor ready for phase II development in oncology from global healthcare company Novo Nordisk.

More... »

FDA approves Tretten to treat rare genetic clotting disorder

Tuesday, January 7, 2014 08:00 AM

The FDA has approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), the first recombinant product for use in the routine prevention of bleeding in adults and children who have a rare clotting disorder, known as congenital Factor XIII A-subunit deficiency.

More... »

Healthcare Leadership Council profiles inVentiv Health

Tuesday, November 26, 2013 10:00 AM

inVentiv Health, a global provider of best-in-class clinical, commercial and consulting services, has announced a cutting-edge inVentiv program for managing the care of chronic kidney disease has been included in a compilation of breakthrough innovations helping transform the American healthcare system.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 27

NIH’s I-Corps boot camp aims to transform researchers into better businesspeople before they launch products

Covance, Frenova form partnership to share patient databases, find effective treatments for renal disease

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs